Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.

Bosn J Basic Med Sci · 2021 · PMC8112554 · PMID 33052081

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Moreover, besides the high degree of personalization in the microbiome, variations in the rate of change of the microbiome between individuals may be significant and should not be neglected [ 44 ].

also in 11,916 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.